Is nafarelin FDA-approved?

Yes, as one product: Synarel nasal spray is FDA-approved for the uses in its label, and it's prescription only.

Checked 1 Nov 2026. The sources are below.

Nafarelin

Also: nafarelin acetate, Synarel

Status label in the Peptimes Library
FDA Approved
Routes in Peptimes
Nasal
Updated
1 Nov 2026

US regulatory status

FDA approval belongs to the product below, for its route and the uses in its label. Label uses are shortened unless quoted.

  • Synarel (nafarelin acetate) nasal spray

    Nasal

    Management of endometriosis, including pain relief and reduction of endometriotic lesions; and central precocious puberty in children of both sexes.

    Source: DailyMed label, checked 1 Nov 2026

  • Prescription

    Prescription only. Drugs@FDA lists the product above as "Prescription".

    Source: Drugs@FDA, checked 1 Nov 2026

  • Investigational

    No, for the product and uses above.

    Source: Drugs@FDA, checked 1 Nov 2026

How to track it in Peptimes

Add nafarelin in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “FDA Approved”; the entry above gives the detail.

  • Logging: the amount you took and how you feel. It’s logged as nasal, so there’s no injection site to record.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell nafarelin or any other compound.

More sources

  • FDA, Drugs@FDA, NDA 019886 (Synarel), checked 1 Nov 2026: product, route and marketing status.
  • FDA, Global Substance Registration System, Nafarelin, checked 1 Nov 2026: its sequence and the name LHRH, 6(D-Nal(2)).

Brand names on this page are trademarks of their owners. Peptimes isn't affiliated with or endorsed by them.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing